Copyright
©The Author(s) 2025.
World J Psychiatry. Aug 19, 2025; 15(8): 107885
Published online Aug 19, 2025. doi: 10.5498/wjp.v15.i8.107885
Published online Aug 19, 2025. doi: 10.5498/wjp.v15.i8.107885
Table 1 Distinct mediating pathways of stigma and their impact on treatment adherence
Mediating pathway | Mechanism of action | Impact on outcomes | Group differences | Ref. |
External stigma → medication literacy → adherence | Social exclusion restructures access to health information through institutional discrimination | Patients avoid reading medication inserts, leading to reduced accuracy in understanding drug interactions; an "information desert" emerges | Cultural specificity exacerbates information-processing difficulties; women may face more barriers in accessing health information | [18-20] |
Internalized stigma → self-efficacy → adherence | Self-stigmatization undermines treatment confidence via cognitive fusion | Patients pathologically associate HIV status with self-worth, showing a "self-punishment" tendency in treatment decisions | Internalized stigma is positively correlated with psychological inflexibility, associated with reduced gray matter density in the anterior insula | [23,24] |
Moderating effects of stigma | Multiple discrimination experiences in racial and sexual minority groups | African American patients exhibit greater distrust toward prescribing intentions; sexual minorities experience unique spatiotemporal stigma burdens | African Americans face dual discrimination (race + HIV status); men who have sex with men report higher internalized stigma in family contexts; transgender women experience a triple-layered stigma effect | [21,27] |
Concealment of treatment behavior | Patients adopt systematic concealment strategies to reduce identity exposure risk | Strategies such as altering appointment times or modifying medical records increase complexity and risk in health management | Women are more likely to use "medication repackaging" due to family role conflicts; men who have sex with men build anonymous support systems through virtual networks | [62-65] |
Table 2 Key psychosocial mediating variables influencing treatment adherence in people living with human immunodeficiency virus
Mediating variable | Definition | Mediating mechanism | Key findings | Ref. |
Stigma | Social stigma and self-stigmatization related to HIV | Affects access to health information and self-efficacy through external and internal stigma pathways | Stigma leads to avoidance of medication information and increased risk of dosage errors; internalized stigma is significantly associated with psychological inflexibility | [21,22] |
Self-efficacy | Patients’ belief in their ability to successfully perform treatment behaviors | Promotes translation of health knowledge into treatment behaviors via the self-regulatory system in social cognitive theory | Higher self-efficacy is significantly associated with better adherence; treatment success reinforces efficacy, forming a positive feedback loop | [31,32] |
Social support | Support from peers, family, and healthcare providers | Provides emotional and informational support, buffers stigma, and enhances self-efficacy | Peer support is strongly linked to long-term retention, adherence, and viral suppression; family support buffers the negative impact of low medication literacy on adherence | [52,53] |
Depression/anxiety | Mental health problems associated with HIV | Alters cognitive processing through functional decoupling of the prefrontal–limbic system | Depression reduces glucose metabolism in the prefrontal cortex, impairing working memory and executive function; anxiety heightens amygdala–insula reactivity, leading to cognitive overload | [58-61] |
Patient–provider trust | Degree of trust patients have in healthcare providers | Enhances the therapeutic alliance and reduces suspicion and fear of the medical system | Lower levels of trust are linked to poorer adherence and outcomes; especially relevant among minority populations | [89] |
Table 3 Mechanisms through which self-efficacy mediates the relationship between medication literacy and treatment adherence
Pathway of action | Neural mechanism | Psychological and behavioral manifestations | Influencing factors | Ref. |
Medication literacy → self-efficacy → adherence | Functional coupling between the prefrontal cortex and striatum enhances executive control network efficiency | Patients accurately interpret medication instructions and anticipate side effects, strengthening their sense of agency in disease management | Culturally adapted health education integrates traditional medical beliefs with modern biomedical knowledge, enhancing confidence in medication use | [33-35] |
Treatment success → reinforced self-efficacy → literacy improvement | Activation of D2 receptors in the striatum enhances neural markers of positive behavioral reinforcement | Patients consistently achieve micro-level treatment goals, forming a feedback loop of "successful experience → efficacy gain → knowledge deepening" | Peer support networks reshape patients’ self-narratives in virtual spaces; trust in healthcare providers modulates dopaminergic projections from the ventral tegmental area to the prefrontal cortex | [43-47] |
Psychodynamic system of behavioral reinforcement | Positive feedback in the dopaminergic reward system drives the acquisition and maintenance of treatment-adherent behavior | High-efficacy patients exhibit a 40% increase in behavioral reinforcement learning rate, especially in managing side effects | Urban living environments offer real-time medical feedback channels; economic empowerment frees cognitive resources for health management | [59,72] |
Dynamic evolution of self-efficacy | Stage-based construction of efficacy across theoretical models | In the initiation phase, trust in healthcare providers plays a central role; in the maintenance phase, the influence of peer support networks increases | Digital interventions using virtual reality simulate medication-taking scenarios, overcoming spatial and temporal limitations of traditional interventions | [61] |
Table 4 Mechanisms through which social support networks influence treatment adherence in people living with human immunodeficiency virus
Type of support | Mechanism of action | Key research findings | Implications for intervention | Ref. |
Peer support | Buffers HIV-related stigma through emotional and informational support | Strongly associated with long-term retention, adherence, and viral suppression among people living with HIV; reduces internalized stigma | Develop peer-based support networks, especially virtual support communities | [47,50,51] |
Family support | Serves as a buffering variable between literacy and adherence, providing emotional and practical aid | Mitigates the negative effects of low medication literacy on adherence; improves adherence through medication reminders and accompaniment to care | Involve family members in medication supervision, especially for children and adolescents | [53] |
Patient–provider trust | Promotes adherence by reducing patients’ suspicion and fear toward the healthcare system | Lower trust is linked to poorer adherence and treatment outcomes; particularly affects racial and ethnic minority groups | Enhance provider communication skills and adopt culturally adaptive strategies | [56] |
Community support networks | Mitigate the negative effects of spatial exclusion by creating alternative healthcare pathways | Community health workers play a key role in sustaining access to antiretroviral therapy; stigma at the community level shapes care-seeking geography | Implement task-sharing interventions with lay providers; build destigmatized support networks | [87] |
Table 5 Research limitations and future directions
Limitation | Specific issues | Future research directions | Suggestions for innovative methods | Ref. |
Lack of longitudinal data | Existing studies predominantly adopt cross-sectional designs, limiting the ability to capture dynamic relationships between psychosocial factors and treatment adherence | Establish longitudinal cohorts integrating biomarkers with behavioral monitoring | Use mobile health technologies for real-time data collection; adopt mixed-method approaches to capture dynamic fluctuations of mediating variables | [100,101] |
Methodological constraints in quantifying mediation effects | The complexity of multiple mediation models challenges traditional statistical methods; failure to account for intergroup heterogeneity may bias effect estimates | Develop hybrid models integrating computational psychiatry and structural equation modeling | Use bias-corrected bootstrap methods to relax normality assumptions in mediation testing; apply Bayesian approaches to improve the accuracy of multilevel mediation models | [102-106] |
Blind spots in evaluating long-term effects of digital interventions | Current digital health studies mainly focus on short-term adherence improvements, lacking exploration of behavior maintenance mechanisms | Construct a "digital intervention life-cycle" evaluation framework | Leverage blockchain technology for decentralized data tracking; include neuroplasticity markers as biomarkers of long-term intervention efficacy | [107-108] |
Insufficient comparative research on cross-cultural interventions | Lack of systematic comparisons of intervention effectiveness across different cultural contexts | Develop a three-dimensional evaluation framework for cross-cultural intervention outcomes | Compare prefrontal–limbic system responses to intervention stimuli across cultural groups; analyze the impact of geographic patterns of community-level stigma on delivery efficiency; evaluate the transferability of cultural archetypes in virtual health communities | — |
- Citation: Xu CH, Hu D, Lin HJ, Yang YD, Li MN, Shao LW. Medication literacy and treatment adherence in people living with human immunodeficiency virus: Mediating effects of psychosocial factors. World J Psychiatry 2025; 15(8): 107885
- URL: https://www.wjgnet.com/2220-3206/full/v15/i8/107885.htm
- DOI: https://dx.doi.org/10.5498/wjp.v15.i8.107885